News & Events

Mar 02, 2021

Press Releases

ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes

Agreement extends research and clinical development across ViaCyte’s full product portfolio and Gore’s full materials and device proprietary technologies Preclinical and clinical studies show that novel membranes and devices designed and developed by the collaboration both improve engraftment and reduce body’s immune reaction ViaCyte’s Phase 2 clinical study of closed device featuring Gore’s novel membrane […]

Read More

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.